INSIGHTS ON LIQUID DOSE MANUFACTURING
-
![GettyImages-1439447135-stem-cell-dna]( "Ensuring Product Safety And Purity With Mycoplasma And Sterility Testing")
Ensuring Product Safety And Purity With Mycoplasma And Sterility TestingDiscover how the Applied Biosystems™ MycoSEQ™ Plus system and Applied Biosystems™ SteriSEQ™ Rapid Sterility Testing System can help accelerate your cell therapy manufacturing process.
-
![GettyImages-1704680401-Clipboard]( "Re-Engineering A Complex Process For FDA Compliance")
Re-Engineering A Complex Process For FDA ComplianceDiscover the strategies that helped a company navigate a complex and shifting regulatory landscape to rapidly re-engineer a COVID-19 vaccine manufacturing process for FDA compliance.
-
![stevanato 1]( "Solutions In Pre-Filled Syringes For Biologics And Ophthalmic Applications")
Solutions In Pre-Filled Syringes For Biologics And Ophthalmic ApplicationsDiscover how pharma companies can select tailored pre-filled syringes for biologics and biosimilars by aligning drug delivery needs with specialized containers and analytical services.
-
![Enhancing Automated Environmental Monitoring In Gloveless Isolators]( "Enhancing Automated Environmental Monitoring In Gloveless Isolators")
Enhancing Automated Environmental Monitoring In Gloveless IsolatorsExplore how automation and robotic-friendly solutions are transforming fill-and-finish operations and gain insights into gloveless processes, EM testing challenges, and collaborative innovations.
-
Innovation In Filtration3/18/2025
Filtration removes contaminants to ensure safety and is essential in various applications, from lab-scale tasks to GMP production. Explore how its simplicity and reliability make it indispensable.
-
Fill-Finish Contract Manufacturing: Trends, Challenges, And The Future9/16/2025
See why it's important to partner with a CDMO that’s investing in advanced sterile fill-finish capabilities to meet the demands of complex biologics, gene therapies, and mRNA-based products.
-
Stability Issues Unique To Liquid Injectables And How To Avoid Them3/23/2026
Liquid injectables face stability risks like oxidation, hydrolysis, aggregation, temperature shifts, and packaging effects, requiring early, rigorous formulation and process controls.
-
Contamination Control Strategies: Comparing Cleanrooms, RABS, Isolators10/20/2025
Sterile manufacturing relies on three main contamination control strategies (CCSs): cleanrooms, RABS, and isolators. Understand how each system compares in sterility assurance, startup cost, and operational flexibility.
-
0.45 m/s ±20% At Working Position In Closed Sterility Testing Isolators: Requirement Or Convention?2/19/2026
Balance compliance and efficiency in sterility testing. Explore how a risk-based approach to airflow and isolator technology aligns with Annex 1 while optimizing contamination control.
LIQUID DOSE MANUFACTURING SOLUTIONS
-
![Aseptic Filling GettyImages-1087219366]( "Drug Product Fill Finish And Formulation Solutions")
Formulation and aseptic filling solutions are crucial at every stage of development. Consider a manufacturing partner who can address every challenge on the path from pre-clinical programs to commercialization.
-
![Bausch Advanced Technologies Aseptic IV Bag Filling and Closing Machine]( "Aseptic IV Bag Filling And Closing Machine")
Unused Bausch Advanced Technologies Aseptic IV Bag Filling and Closing Machine, Type 526, speeds up to 6,000 bags/hour, intermittent motion filling system, with (2) bag infeed stations (1) on each side of with pick and place units. (8) dosing and filling stations, (4) 2 up stations, mass flow measuring system, servo-driven filling motion, CIP design, bag stoppering system, with (8) stations, (4) 2 up stations with stopper feed bowls, bag reject station, PLC controls with HMI touch screen. System mounted in RABS barrier system. Built in 2017 and still on shipping skid. Serial #526006.
-
![ASEPTiCell]( "Isolator Barrier Pharmaceutical Aseptic Filling Systems")
ASEPTiCell is integrated with isolator-barrier technologies to fully enclose and tightly control the aseptic environment for ideal conditions for processing sterile drug products. The system can be configured with a Restricted Access Barrier System (RABS) or an aseptic isolator to provide uninterrupted aseptic conditions during production. With isolator integrated systems, the ASEPTiCell is completely compatible with repeated in-situ bio-decontamination using hydrogen peroxide to further enhance the sterility assurance of the system.
-
![flexiblecontainmentisolators]( "Flexible Containment Isolators")
Flexible Containment Isolators provide containment standards better than can be achieved with Downflow Booth technology, and often compare favorably with a Rigid Isolator system.
-
![Esco- Cell Processing Isolator (CPI)]( "Cell Processing Isolator")
Advance your cell processing capabilities with high-containment isolation. Ensure cGMP compliance and superior sterile protection for your most sensitive and critical biological workflows.
